176 related articles for article (PubMed ID: 27617577)
21. Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma.
Maftouh M; Belo AI; Avan A; Funel N; Peters GJ; Giovannetti E; Van Die I
Oncotarget; 2014 Jul; 5(14):5335-49. PubMed ID: 24977327
[TBL] [Abstract][Full Text] [Related]
22. Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.
Sano M; Ichimaru Y; Kurita M; Hayashi E; Homma T; Saito H; Masuda S; Nemoto N; Hemmi A; Suzuki T; Miyairi S; Hao H
Cancer Lett; 2017 Jul; 397():72-82. PubMed ID: 28347789
[TBL] [Abstract][Full Text] [Related]
23. A pharmacogenomic analysis using L1000CDS
Choi EA; Choi YS; Lee EJ; Singh SR; Kim SC; Chang S
Cancer Lett; 2019 Nov; 465():82-93. PubMed ID: 31404615
[TBL] [Abstract][Full Text] [Related]
24. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells.
Merlin J; Stechly L; de Beaucé S; Monté D; Leteurtre E; van Seuningen I; Huet G; Pigny P
Oncogene; 2011 Jun; 30(22):2514-25. PubMed ID: 21258405
[TBL] [Abstract][Full Text] [Related]
25. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
26. Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest.
Kobayashi K; Morishita A; Iwama H; Fujita K; Okura R; Fujihara S; Yamashita T; Fujimori T; Kato K; Kamada H; Niki T; Hirashima M; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2015 Oct; 34(4):1761-70. PubMed ID: 26260906
[TBL] [Abstract][Full Text] [Related]
27. Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer.
Takiguchi S; Inoue K; Matsusue K; Furukawa M; Teramoto N; Iguchi H
Int J Oncol; 2017 Jul; 51(1):184-192. PubMed ID: 28498406
[TBL] [Abstract][Full Text] [Related]
28. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
29. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
[TBL] [Abstract][Full Text] [Related]
30. [Effects and mechanisms of combined suppression of epidermal growth factor receptor and hedgehog signaling on proliferation in pancreatic cancer cells].
Qin CF; Tian XD; Hao K; Yang YM
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(26):1849-53. PubMed ID: 22944238
[TBL] [Abstract][Full Text] [Related]
31. Galectin-3's Complex Interactions in Pancreatic Ductal Adenocarcinoma: From Cellular Signaling to Therapeutic Potential.
Dimitrijevic Stojanovic M; Stojanovic B; Radosavljevic I; Kovacevic V; Jovanovic I; Stojanovic BS; Prodanovic N; Stankovic V; Jocic M; Jovanovic M
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892182
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.
Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X
Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897
[TBL] [Abstract][Full Text] [Related]
33. The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice.
Miknyoczki SJ; Wan W; Chang H; Dobrzanski P; Ruggeri BA; Dionne CA; Buchkovich K
Clin Cancer Res; 2002 Jun; 8(6):1924-31. PubMed ID: 12060637
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines.
Pino MS; Shrader M; Baker CH; Cognetti F; Xiong HQ; Abbruzzese JL; McConkey DJ
Cancer Res; 2006 Apr; 66(7):3802-12. PubMed ID: 16585207
[TBL] [Abstract][Full Text] [Related]
35. An arabinogalactan from flowers of Panax notoginseng inhibits angiogenesis by BMP2/Smad/Id1 signaling.
Wang P; Zhang L; Yao J; Shi Y; Li P; Ding K
Carbohydr Polym; 2015 May; 121():328-35. PubMed ID: 25659706
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB
Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757
[TBL] [Abstract][Full Text] [Related]
37. A novel NHE1-centered signaling cassette drives epidermal growth factor receptor-dependent pancreatic tumor metastasis and is a target for combination therapy.
Cardone RA; Greco MR; Zeeberg K; Zaccagnino A; Saccomano M; Bellizzi A; Bruns P; Menga M; Pilarsky C; Schwab A; Alves F; Kalthoff H; Casavola V; Reshkin SJ
Neoplasia; 2015 Feb; 17(2):155-66. PubMed ID: 25748234
[TBL] [Abstract][Full Text] [Related]
38. Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis.
Choi YS; Kim MJ; Choi EA; Kim S; Lee EJ; Park MJ; Kim MJ; Kim YW; Ahn HS; Jung JY; Jang G; Kim Y; Kim H; Kim K; Kim JY; Hong SM; Kim SC; Chang S
Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2119048119. PubMed ID: 35858411
[TBL] [Abstract][Full Text] [Related]
39. Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR/FAK pathway.
Tang Q; Wang Y; Ma L; Ding M; Li T; Nie Y; Gu Z
Oncol Rep; 2018 Mar; 39(3):1299-1305. PubMed ID: 29328433
[TBL] [Abstract][Full Text] [Related]
40. Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis-inducing ability.
Li YY; Wang YY; Taniguchi T; Kawakami T; Baba T; Ishibashi H; Mukaida N
Int J Cancer; 2010 Jul; 127(2):474-84. PubMed ID: 19921695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
